Covalon is a widely held public company listed on the TSX Venture Exchange (Ticker: COV) since 2004. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Our technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.  Our corporate offices and laboratories are located in Mississauga, Canada.